Edition:
United Kingdom

Akers Biosciences Inc (AKER.OQ)

AKER.OQ on NASDAQ Stock Exchange Capital Market

0.41USD
15 Dec 2017
Change (% chg)

$0.03 (+9.22%)
Prev Close
$0.38
Open
$0.37
Day's High
$0.42
Day's Low
$0.37
Volume
72,639
Avg. Vol
51,400
52-wk High
$2.85
52-wk Low
$0.36

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.68 -0.132
Jun '17 1.20 -0.075
Mar '17 0.67 -0.193
FY 2016 Dec '16 0.65 -0.202
Sep '16 0.61 0.056
Jun '16 0.96 -0.186
Mar '16 0.74 -0.278
FY 2015 Dec '15 0.47 -0.695
Sep '15 0.17 -0.452
Jun '15 0.97 -0.405
Mar '15 0.51 -0.258
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 1 1.56 1.56 1.56 --
Year Ending Dec-17 1 3.42 3.42 3.42 --
Year Ending Dec-18 1 8.17 8.17 8.17 --
Earnings (per share)
Quarter Ending Dec-17 1 4.45 4.45 4.45 --
Year Ending Dec-17 1 -25.23 -25.23 -25.23 --
Year Ending Dec-18 1 10.39 10.39 10.39 --
Sales and Profit Figures in British Pound (GBP);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.66 32.93
P/E High - Last 5 Yrs. -- 290.77 45.62
P/E Low - Last 5 Yrs. -- 93.67 24.34
Beta -0.12 0.85 0.88
Price to Sales (TTM) 2.46 100.68 5.40
Price to Book (MRQ) 1.51 13.50 5.38
Price to Tangible Book (MRQ) 1.97 13.43 6.78
Price to Cash Flow (TTM) -- 76.24 23.45
% Owned Institutions 23.89 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 25.23 433.88 9.00
Sales (TTM) vs TTM 1 Yr. Ago 34.25 75.04 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago 59.63 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago 74.35 -- --
EPS - 5 Yr. Growth Rate -- 43.18 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.89 1.68 2.18
Current Ratio (MRQ) 3.39 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.93 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -111.94 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 63.94 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -80.94 -- --
EBITD - 5 Yr. Avg -- -261.13 15.24
Operating Margin (TTM) -90.32 -556.69 7.76
Operating Margin - 5 Yr. Avg. -- -279.31 10.75
Pre-Tax Margin (TTM) -89.46 -529.93 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.05 11.17
Net Profit Margin (TTM) -89.46 -531.37 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.22 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 111,840 25,316,769 864,680,848
Net Income/Employee (TTM) -100,057 3,332,346 101,718,394
Receivable Turnover (TTM) 3.85 21.54 5.76
Inventory Turnover (TTM) 0.67 2.01 3.34
Asset Turnover (TTM) 0.51 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -45.75 -0.77 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -60.68 2.36 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -60.68 2.96 16.05
Return on Equity - 5 Yr. Avg. -- 6.41 17.51
  1 Year 3 Year 5 Year
Sales % 39.99 -6.11 --
EPS (TTM) % 66.41 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akers Biosciences Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -9.90 -13.00 19 53
13 Week -27.92 -31.43 13 60
26 Week -46.77 -50.82 13 69
52 Week -73.98 -77.95 6 46
YTD -54.47 -60.02 9 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 18.24%
# of Holders: 21
Total Shares Held: 1,809,837
3 Mo. Net Change: -410,952
# New Positions: 3
# Closed Positions: 2
# Increased Positions: 6
# Reduced Positions: 7
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.